SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-081686
Filing Date
2023-07-17
Accepted
2023-07-17 17:18:15
Documents
14
Period of Report
2023-07-13
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2321435d1_8k.htm   iXBRL 8-K 41235
2 EXHIBIT 99.1 tm2321435d1_ex99-1.htm EX-99.1 8279
  Complete submission text file 0001104659-23-081686.txt   289409

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pmgm-20230713.xsd EX-101.SCH 4059
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pmgm-20230713_def.xml EX-101.DEF 27706
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pmgm-20230713_lab.xml EX-101.LAB 39306
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pmgm-20230713_pre.xml EX-101.PRE 26326
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2321435d1_8k_htm.xml XML 6893
Mailing Address 300 SE 2ND STREET SUITE 600 FORT LAUDERDALE FL 33301
Business Address 300 SE 2ND STREET SUITE 600 FORT LAUDERDALE FL 33301 (407) 808-1335
Priveterra Acquisition Corp. (Filer) CIK: 0001837607 (see all company filings)

IRS No.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40021 | Film No.: 231092365
SIC: 2834 Pharmaceutical Preparations